Advancy is proud to have supported CVC in its agreement to acquire a majority stake in WillowWood, alongside Blue Sea Capital, the Arbogast family, and the management team.

This strategic partnership marks a major milestone for WillowWood, a leading designer and manufacturer of prosthetic solutions. The collaboration aims to accelerate growth, foster innovation, and expand international reach.

Strategic Growth and Innovation Pillars

The strategic investment focuses on key initiatives to scale WillowWood’s footprint and impact:

• R&D Investment: Accelerating research and development to drive technological advancements in prosthetics.

• Product Innovation: Expanding the portfolio with next-generation solutions tailored to patient needs.

• Global Expansion: Strengthening direct commercial presence, particularly across European markets.

Driving Value in Strategy & M&A

At Advancy, we combine deep industry expertise with rigorous strategic analysis to support leading private equity firms and corporations throughout the deal lifecycle.

Congratulations to all the teams involved in reaching this promising milestone!

Discover Our Expertise

To learn more about how Advancy supports private equity and corporate strategy transactions worldwide, explore our consulting services.